Article in Life (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors at 4 institutions in 1 country.
Joanna BartosińskaDepartment of Cosmetology and Aesthetic Medicine, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0003-4106-3051
Szymon ZmorzyńskiDepartment of Cancer Genetics with Cytogenetic Laboratory, Medical University of Lublin, 20-080 Lublin, Poland.
Beata Sarecka-HujarDepartment of Basic Biomedical Science, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 41-200 Sosnowiec, Poland.ORCID 0000-0003-0002-8591
Dorota RaczkiewiczDepartment of Medical Statistics, School of Public Health, Center of Postgraduate Medical Education, 01-826 Warsaw, Poland.ORCID 0000-0003-3517-6711
Magdalena Wojcierowska-LitwinDepartment of Cancer Genetics with Cytogenetic Laboratory, Medical University of Lublin, 20-080 Lublin, Poland.
Iwona Korszeń-PileckaDepartment of Cancer Genetics with Cytogenetic Laboratory, Medical University of Lublin, 20-080 Lublin, Poland.
Anna Michalak-StomaDepartment of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, 20-081 Lublin, Poland.ORCID 0000-0002-4599-6249
Małgorzata KowalDepartment of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, 20-081 Lublin, Poland.
Jarosław BartosińskiDepartment of Anaesthesiology and Intensive Therapy, Independent Public Clinical Hospital No. 4 in Lublin, 20-097 Lublin, Poland.
Agata FilipDepartment of Cancer Genetics with Cytogenetic Laboratory, Medical University of Lublin, 20-080 Lublin, Poland.ORCID 0000-0001-7591-5887
Dorota KrasowskaDepartment of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, 20-081 Lublin, Poland.ORCID 0000-0002-3176-9870
Grażyna ChodorowskaDepartment of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, 20-081 Lublin, Poland.
Medical University of Lublin · PL1 Military Clinical Hospital with Outpatient Clinic · PLMedical University of Silesia · PLPostgraduate School of Molecular Medicine · PL
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Advances in genotypic technologies enable identification of possible associations between genetic variants of certain genes and increased risk of developing plaque psoriasis or psoriatic arthritis. The aim of the study was to analyze the
Indexed as
genetics of psoriasisNOTCH3 polymorphismPSMA6 polymorphismpsoriasis
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
The Genetic Variants of NOTCH3 (6746T>C) and PSMA6 (-8C>G) as Possible Risk Factors of Psoriasis Development. · full record | OpenQuestion